Health and Healthcare
Dendreon Gives Quarterly Report & Provenge Updates (DNDN)
Published:
Last Updated:
Dendreon Corp. (NASDAQ: DNDN) has its quarterly results out, although it is via SEC Filing rather than via a press release. We had this on deck for a report this week and a conference call was set for Tuesday at 11:30 AM EST.
Dendreon’s total operating expenses were $20.929 million and net loss after items of $126.7 million after a $105+ million warrant item. That is not just from operations and it does include many ongoing or new items. That comes to a loss of $1.20 EPS and revenues were listed as $25,000.00.
More importantly, the company disclosed its expansion facilities and the associated costs in Georgia and in California. Dendreon is still expecting PROVENGE to be approved and it gave updates along those lines.
FULL DETAILS of the financial data and updates on Provenge are at BioHealthInvestor.com.
Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
